Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Outcomes and Treatment Patterns in Brazilian Patients With Hormone Receptor Positive / HER2-negative Unresectable or Metastatic Breast Cancer

NCT06676436 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06676436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06676436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Outcomes and Treatment Patterns in Brazilian Patients With Hormone Receptor Positive / HER2-negative Unresectable or Metastatic Breast Cancer
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2024
Completion date
December 31, 2025
Enrollment
204 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cancer